Biophan Technologies, Inc. 

(Public, OTC:BIPH)   Watch this stock   
Find more results for BIPH

Key stats and ratios

Q1 (Feb '09) 2009
Net profit margin -199.12% -1112.98%
Operating margin -204.87% -851.33%
EBITD margin - -729.65%
Return on average assets -42.36% -48.82%
Return on average equity -112.91% -90.58%
Employees 2 -

Address

15 SCHOEN PLACE
Pittsford, NY 14534
United States - Map
+1-585-2674800 (Phone)
+1-585-4272433 (Fax)

Website links

External links

Discussion Group - Google Finance

Description

Biophan Technologies, Inc. (Biophan) is a technology development and holding company focused on the creation and sale of patent protected technologies and medical devices including magnetic resonance imaging (MRI) compatible implants and devices, and circulatory support systems. The Company possesses technologies for enabling biomedical devices, both implantable and those used in diagnostic and interventional procedures, to be safe and image compatible with magnetic resonance imaging (MRI). The Company is also developing and marketing a system for generating power for implantable devices from body heat, and a series of implantable devices including MRI-visible vascular implants, such as a vena cava filter, a heart valve and an occluder for the treatment of atrial septal defects, a hole in the wall separating the left and right chambers of the heart. Its first licensee for several of these technologies was Boston Scientific.

Officers and directors

Stan Yakatan
Chairman of the Board
Age: 65
John F. Lanzafame
Chief Executive Officer, Director
Age: 41
Margaret Virginia Russell
Chief Financial Officer, Treasurer, Secretary
Age: 43
Theodore A. Greenberg
Director
Age: 49
Harold R. Gubnitsky B.Sc.
Director
Age: 46